• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国际腹膜透析利用的差异及其对实践的影响。

International Variations in Peritoneal Dialysis Utilization and Implications for Practice.

机构信息

University of Sheffield, Sheffield, United Kingdom.

University of Keele, Keele, United Kingdom.

出版信息

Am J Kidney Dis. 2019 Jul;74(1):101-110. doi: 10.1053/j.ajkd.2018.12.033. Epub 2019 Feb 22.

DOI:10.1053/j.ajkd.2018.12.033
PMID:30799030
Abstract

In many countries, the use of peritoneal dialysis (PD) remains low despite arguments that support its greater use, including dialysis treatment away from hospital settings, avoidance of central venous catheters, and potential health economic advantages. Training patients to manage aspects of their own care has the potential to enhance health literacy and increase patient involvement, independence, quality of life, and cost-effectiveness of care. Complex reasons underlie the variable use of PD across the world, acting at the level of the patient, the health care team that is responsible for them, and the health care system that they find themselves in. Important among these is the availability of competitively priced dialysis fluid. A number of key interventions can affect the uptake of PD. These include high-quality patient education around dialysis modality choice, timely and successful catheter placement, satisfactory patient training, and continued support that is tailored for specific needs, for example, when people present late requiring dialysis. Several health system changes have been shown to increase PD use, such as targeted funding, PD First initiatives, or physician-inserted PD catheters. This review explores the factors that explain the considerable international variation in the use of PD and presents interventions that can potentially affect them.

摘要

在许多国家,尽管有论据支持更多地使用腹膜透析(PD),包括在医院环境之外进行透析治疗、避免使用中心静脉导管,以及具有潜在的健康经济效益,但 PD 的使用仍然很低。培训患者管理自身护理的各个方面,有可能提高健康素养,增加患者的参与度、独立性、生活质量以及护理的成本效益。复杂的原因导致 PD 在全球的使用情况存在差异,这些原因存在于患者、负责他们的医疗保健团队以及他们所处的医疗保健系统三个层面。其中重要的一点是价格有竞争力的透析液的供应情况。一些关键的干预措施可以影响 PD 的采用。这些措施包括围绕透析方式选择进行高质量的患者教育、及时和成功的置管、令患者满意的培训,以及根据具体需求提供的持续支持,例如,当人们需要透析时已经很晚了。已经有多项卫生系统的改变被证明可以增加 PD 的使用,例如有针对性的资金投入、PD 优先倡议或医生插入 PD 导管。本综述探讨了导致 PD 使用情况在国际上存在巨大差异的因素,并介绍了可能影响这些因素的干预措施。

相似文献

1
International Variations in Peritoneal Dialysis Utilization and Implications for Practice.国际腹膜透析利用的差异及其对实践的影响。
Am J Kidney Dis. 2019 Jul;74(1):101-110. doi: 10.1053/j.ajkd.2018.12.033. Epub 2019 Feb 22.
2
Dialysis Care and Dialysis Funding in Asia.亚洲的透析护理和透析资金
Am J Kidney Dis. 2020 May;75(5):772-781. doi: 10.1053/j.ajkd.2019.08.005. Epub 2019 Nov 5.
3
Peritoneal Dialysis Use and Practice Patterns: An International Survey Study.腹膜透析的使用和实践模式:一项国际调查研究。
Am J Kidney Dis. 2021 Mar;77(3):315-325. doi: 10.1053/j.ajkd.2020.05.032. Epub 2020 Aug 12.
4
Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies.医疗保健系统与终末期肾病(ESRD)治疗——一项国际综述:ESRD治疗的成本及报销/资金情况
Nephrol Dial Transplant. 1999;14 Suppl 6:31-41. doi: 10.1093/ndt/14.suppl_6.31.
5
Success of Urgent-Start Peritoneal Dialysis in a Large Canadian Renal Program.加拿大一项大型肾脏项目中紧急启动腹膜透析的成功案例
Perit Dial Int. 2016 Mar-Apr;36(2):171-6. doi: 10.3747/pdi.2014.00148. Epub 2015 Sep 15.
6
Comparison of outcomes between emergent-start and planned-start peritoneal dialysis in incident ESRD patients: a prospective observational study.新发终末期肾病患者中紧急开始与计划开始腹膜透析的结局比较:一项前瞻性观察研究。
BMC Nephrol. 2017 Dec 11;18(1):359. doi: 10.1186/s12882-017-0764-6.
7
Assisted peritoneal dialysis as a method of choice for elderly with end-stage renal disease.辅助性腹膜透析作为老年终末期肾病患者的首选治疗方法。
Int Urol Nephrol. 2008;40(4):1143-50. doi: 10.1007/s11255-008-9427-7. Epub 2008 Jul 23.
8
Changing Landscape for Peritoneal Dialysis: Optimizing Utilization.腹膜透析的变革格局:优化利用
Semin Dial. 2017 Mar;30(2):149-157. doi: 10.1111/sdi.12576. Epub 2017 Feb 1.
9
PD First: peritoneal dialysis as the default transition to dialysis therapy.优先选择腹膜透析:将腹膜透析作为透析治疗的默认过渡方式。
Semin Dial. 2013 Nov-Dec;26(6):706-13. doi: 10.1111/sdi.12125. Epub 2013 Sep 19.
10
Urgent-start peritoneal dialysis: a chance for a new beginning.紧急启动腹膜透析:新的开始的机会。
Am J Kidney Dis. 2014 Mar;63(3):390-5. doi: 10.1053/j.ajkd.2013.09.018. Epub 2013 Nov 15.

引用本文的文献

1
Correlation of the triglyceride-glucose-body mass index with all-cause and cardiovascular mortality in patients undergoing peritoneal dialysis: a retrospective cohort study.甘油三酯-血糖-体重指数与腹膜透析患者全因死亡率和心血管死亡率的相关性:一项回顾性队列研究
Front Nutr. 2025 Aug 20;12:1612402. doi: 10.3389/fnut.2025.1612402. eCollection 2025.
2
Outcomes of Initiating Peritoneal Dialysis versus Hemodialysis in Severe, Symptomatic Kidney Failure.重度症状性肾衰竭患者开始腹膜透析与血液透析的治疗效果比较
Kidney360. 2025 Jul 22;6(8):1373-1383. doi: 10.34067/KID.0000000863.
3
Dietary energy intake predicts mortality in Chinese patients with peritoneal dialysis: a single-center 18 years' follow-up study.
膳食能量摄入可预测中国腹膜透析患者的死亡率:一项单中心18年随访研究。
BMC Nephrol. 2025 Mar 5;26(1):120. doi: 10.1186/s12882-025-04051-0.
4
Real-world effectiveness of hemodialysis modalities: a retrospective cohort study.血液透析方式的真实世界有效性:一项回顾性队列研究。
BMC Nephrol. 2025 Jan 7;26(1):9. doi: 10.1186/s12882-024-03934-y.
5
Probiotic interventions in peritoneal dialysis: A review of underlying mechanisms and therapeutic potentials.益生菌干预在腹膜透析中的应用:潜在机制与治疗潜力综述
World J Nephrol. 2024 Dec 25;13(4):98719. doi: 10.5527/wjn.v13.i4.98719.
6
Inflammatory Burden Index: A Superior Prognostic Biomarker of Systemic Inflammation in Patients on Peritoneal Dialysis.炎症负担指数:腹膜透析患者全身炎症的一种优越的预后生物标志物。
J Inflamm Res. 2024 Dec 11;17:10913-10927. doi: 10.2147/JIR.S393291. eCollection 2024.
7
Dyslipidemia in Peritoneal Dialysis: Implications for Peritoneal Membrane Function and Patient Outcomes.腹膜透析中的血脂异常:对腹膜功能和患者预后的影响。
Biomedicines. 2024 Oct 17;12(10):2377. doi: 10.3390/biomedicines12102377.
8
International equity in access to home dialysis.国际上在家庭透析方面的可及性公平性。
Curr Opin Nephrol Hypertens. 2025 Jan 1;34(1):112-120. doi: 10.1097/MNH.0000000000001027. Epub 2024 Sep 19.
9
Home dialysis: advantages and limitations.家庭透析:优势与局限
Clin Kidney J. 2024 Jul 3;17(7):sfae180. doi: 10.1093/ckj/sfae180. eCollection 2024 Jul.
10
Prescribing Peritoneal Dialysis in the United States.在美国开具腹膜透析处方。
Clin J Am Soc Nephrol. 2024 Jun 1;19(6):688-690. doi: 10.2215/CJN.0000000000000481. Epub 2024 May 17.